NMC Health (LON:NMC) had its price target decreased by Jefferies Financial Group from GBX 2,077 ($27.14) to GBX 1,986 ($25.95) in a report published on Tuesday morning, ThisIsMoney.Co.Uk reports. Jefferies Financial Group currently has an underperform rating on the stock.
NMC has been the topic of a number of other research reports. Berenberg Bank restated a buy rating and issued a GBX 3,050 ($39.85) target price on shares of Cranswick in a research note on Tuesday, May 28th. Barclays reiterated an underweight rating on shares of in a research note on Thursday, July 4th. Finally, Goldman Sachs Group downgraded SPECTRIS PLC/ADR from a neutral rating to a sell rating in a research note on Monday, March 25th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the stock. NMC Health presently has a consensus rating of Buy and a consensus target price of GBX 3,764.33 ($49.19).
Shares of NMC opened at GBX 2,230 ($29.14) on Tuesday. NMC Health has a one year low of GBX 2,110 ($27.57) and a one year high of GBX 4,376 ($57.18). The company’s fifty day simple moving average is GBX 2,371.88. The firm has a market capitalization of $4.66 billion and a price-to-earnings ratio of 18.77. The company has a debt-to-equity ratio of 150.61, a current ratio of 1.45 and a quick ratio of 1.16.
About NMC Health
NMC Health Plc provides healthcare services in the United Arab Emirates, Spain, and internationally. The company operates through two businesses, NMC Healthcare and NMC Trading. It owns and manages approximately 135 healthcare facilities that include hospitals, medical centers, long term care facilities, day surgery centers, fertility centers, and home health services providers.
Further Reading: Oversold
Receive News & Ratings for NMC Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NMC Health and related companies with MarketBeat.com's FREE daily email newsletter.